Patent Assignment
Reel/Frame 012831/0709
Assignment of Assignor's Interest
Recorded: 2002-04-23
Pages: 5
Assignor
LYNX THERAPEUTICS, INC.
Executed: 2002-04-02
Assignee
GERON CORPORATION
230 CONSTITUTION DRIVE, MENLO PARK, CALIFORNIA, 94025
Covered Properties
(10)
Oligonucleotide N3'-P5' Phosphoramidates: Hybridization and Nuclease Resistance Properties
Patent:
5,599,922 →
Application:
08/214,599 →
Oligonucleotide N3'-P5' Phosphoramidates: Hybridization and Nuclease Resistance Properties
Patent:
5,631,135 →
Application:
08/473,015 →
Oligonucleotide N3'-P5' Phosphoramidates: Hybridization and Nuclease Resistance Properties
Patent:
5,837,835 →
Application:
08/477,306 →
Oligonucleotide N3'-P5' Phosphoramidates: Triplex Dna Formation
Patent:
5,591,607 →
Application:
08/478,470 →
Oligo-2'-Fluoronucleotide N3'->P5' Phosphoramidates
Patent:
5,684,143 →
Application:
08/603,566 →
Solid Phase Synthesis of Oligonucleotide N3' P5' Phosphoramidates
Patent:
5,824,793 →
Application:
08/663,918 →
Oligonucleotide N3' P5' Phosphoramidates
Patent:
5,965,720 →
Application:
08/700,448 →
Synthons for Synthesis of Oligonucleotide N3-P5 Phosphoramidates
Patent:
5,859,233 →
Application:
08/771,789 →
Oligonucleotide N3' -> N5' Phosphoramidates: Hybridization and Nuclease Resistance Properties
Patent:
6,169,170 →
Application:
08/923,386 →
Polynucleotide Purification Method
Patent:
5,998,604 →
Application:
08/929,620 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 1994
From: GRYAZNOV, SERGEI M.
To: LYNX THERAPEUTICS, INC., A CA CORP.
Reel/Frame 007071/0134 →
Corrected Assignment Recorded on Reel 7071, Frame 134 to Correct the State of Incorporation of Assignee.
Dec 2, 1994
From: GRYAZNOV, SERGEI M.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007233/0708 →
Assignment of Assignor's Interest
May 7, 1996
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.; CHEN, JER-KANG
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007937/0678 →
Assignment of Assignor's Interest
May 7, 1996
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.; CHEN, JER-KANG
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007941/0710 →
Assignment of Assignor's Interest
May 7, 1996
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.; CHEN, JER-KANG
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007942/0774 →
Assignment of Assignor's Interest
Jul 29, 1996
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.; CHEN, JER-KANG
To: LYNX THERAPEUTICS, INC.
Reel/Frame 008069/0294 →
Assignment of Assignor's Interest
Sep 9, 1996
From: HIRSCHBEIN, BERNARD L.; FEARON, KAREN L.; GRYAZNOV, SERGEI M.; MCCURDY, SARAH N.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 008132/0637 →
Assignment of Assignor's Interest
Jul 7, 1997
From: HIRSCHBEIN, BERNARD L.; FEARON, KAREN L.; GRYAZNOV, SERGEI M.; MCCURDY, SARAH N.
To: LYNX THERAPEUTICS, INC., A DE CORP.
Reel/Frame 008635/0592 →
Assignment of Assignor's Interest
Aug 7, 1997
From: TEXAS INSTRUMENTS INCORPORATED; TEXAS INSTRUMENTS DEUTSCHLAND GMBH
To: RAYTHEON TI SYSTEMS, INC.
Reel/Frame 008628/0414 →
Assignment of Assignor's Interest
Mar 2, 1998
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.; CHEN, JER-KANG
To: LYNX THERAPEUTICS, INC. A DELAWARE CORPORATION
Reel/Frame 009032/0583 →
Assignment of Assignor's Interest
Mar 16, 1998
From: GRYAZNOV, SERGEI M.; SCHULTZ, RONALD G.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 009038/0260 →
Assignment of Assignor's Interest
Mar 16, 1998
From: FEARON, KAREN L.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 009049/0031 →
Assignment of Assignor's Interest
Mar 16, 1998
From: BOYD, VICTORIA LEE
To: PERKIN-ELMER CORPORATION, THE, A NEW YORK CORP.
Reel/Frame 009049/0043 →
Merger
Jan 7, 2014
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 031908/0216 →
Change of Name
Jan 7, 2014
From: PE CORPORATION
To: APPLERA CORPORATION
Reel/Frame 031935/0535 →
Merger
Jan 7, 2014
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 031908/0347 →
Merger
Jan 7, 2014
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 031908/0315 →